glp 1 based therapy Expanding applications of therapies on GLP1 GLP-1 Therapy for Diabetes and
Description
Some people have receptor variants that make them more or less responsive to GLP-1 agonists
95% CI, 2.022.74), as shown in Figure 3
GLP-1, short for Glucagon-Like Peptide-1, is a naturally occurring hormone in the body that plays a key role in regulating blood sugar and appetite
Bando, H
Safety profile The safety assessment of GLP-1 receptor agonists indicates a mostly gastrointestinal side effect profile, characterised by dose-dependent symptoms that are often treatable by meticulous titration (Madsbad 2016)
